| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.741 | 78.441 | 117.134 | 145.715 | 175.883 | 150.322 | 131.478 | 165.875 | 198.911 | 222.047 |
| Total Income - EUR | 11.741 | 78.442 | 117.172 | 146.808 | 177.927 | 152.469 | 131.478 | 165.875 | 198.911 | 222.047 |
| Total Expenses - EUR | 25.387 | 51.239 | 71.064 | 89.217 | 111.983 | 97.528 | 92.514 | 108.869 | 140.583 | 165.946 |
| Gross Profit/Loss - EUR | -13.646 | 27.203 | 46.108 | 57.591 | 65.945 | 54.941 | 38.964 | 57.006 | 58.327 | 56.101 |
| Net Profit/Loss - EUR | -13.998 | 26.417 | 44.936 | 56.116 | 64.152 | 53.387 | 37.628 | 55.311 | 56.325 | 51.182 |
| Employees | 1 | 5 | 3 | 3 | 3 | 5 | 5 | 2 | 2 | 3 |
Check the financial reports for the company - Visioclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.978 | 8.808 | 37.204 | 31.720 | 26.636 | 21.236 | 25.670 | 29.193 | 22.513 | 68.952 |
| Current Assets | 11.134 | 28.328 | 43.458 | 51.885 | 54.913 | 53.459 | 50.186 | 55.489 | 77.981 | 83.644 |
| Inventories | 11.110 | 25.845 | 34.901 | 42.772 | 40.417 | 35.786 | 44.070 | 52.496 | 70.160 | 48.948 |
| Receivables | 20 | 1.679 | 2.796 | 191 | 150 | 9.811 | 221 | 779 | 1.436 | 27.932 |
| Cash | 4 | 805 | 5.761 | 8.921 | 14.347 | 7.862 | 5.896 | 2.214 | 6.385 | 6.765 |
| Shareholders Funds | -13.931 | 12.628 | 45.015 | 56.194 | 64.228 | 59.990 | 55.054 | 62.819 | 69.152 | 51.254 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 35.043 | 24.576 | 35.708 | 27.410 | 17.384 | 14.755 | 20.802 | 21.863 | 31.470 | 101.434 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Visioclinic Srl